Matshidiso Moeti | |
---|---|
Born | Greater Johannesburg area, South Africa | March 13, 1954
Nationality | Botswana |
Alma mater | University of London (Bachelor of Medicine and Bachelor of Surgery) [1] London School of Hygiene and Tropical Medicine (Master of Science in Community Health for Developing Countries) [1] |
Occupations | |
Years active | 1980s — present |
Title | Regional Director WHO Regional Office for Africa |
Matshidiso Rebecca Natalie Moeti is a physician, public health specialist and medical administrator from Botswana who has been serving as Regional Director of the World Health Organization Regional Office for Africa (AFRO), headquartered in Brazzaville, the Republic of the Congo, since 2015. [2]
Moeti was born in South Africa in the 1950s.
In 1978, she obtained her Bachelor of Medicine and Bachelor of Surgery degree from the Royal Free Hospital School of Medicine of the University of London. Later, in 1986, she graduated with a Master of Science in Community Health for Developing Countries from the London School of Hygiene and Tropical Medicine. [1]
In the early 1990s, Moeti worked for the Botswana Ministry of Health. She then joined UNAIDS, rising to the position of Team Leader of the Africa and Middle East Desk, based in Geneva, from 1997 until 1999. She also served as the Regional Health Advisor for UNICEF’s Regional Office for East and Southern Africa. [3]
In 1999, Moeti joined the WHO Regional Office in Africa, working on HIV/AIDS. She was appointed as Assistant Regional Director, serving in that capacity from 2008 until 2011. She also served as the Director of Noncommunicable Diseases at the regional office. From 2005 until 2007, she served as the WHO Country Representative in Malawi. At the time of her appointment to her current position, she was the Coordinator of the Inter-Country Support Team for the South and East African countries of WHO African Region. [4]
Moeti was appointed as Regional Director of the WHO Regional Office for Africa on 27 January 2015, by the WHO Executive Board sitting at its 136th session in Geneva, Switzerland. She became the first woman to head the office. [5] She assumed office on 1 February 2015, to serve a renewable five-year term. [4] This followed the endorsement of the health ministers of the 47 member countries in the Africa Region, at their meeting in Cotonou, Benin, in November 2014. She replaced Luis Gomes Sambo of Angola, who served as the Director of AFRO from 2005 until 2015. [6] She was reelected for a second term in 2019. [7]
Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.
Professor Sheila Dinotshe Tlou is a Botswana nurse, specialist in HIV/AIDS and women's health, and a nursing educator. She was Minister of Health from 2004 to 2008. Professor Tlou is a distinguished advocate for human resources for health issues. She is a recognized visionary leader and champion.
Jean Marie Okwo-Bele is a Congolese physician, public health expert and former Director of the Department of Immunization, Vaccines and Biologicals of the World Health Organization (WHO).
Ilona Kickbusch is a German political scientist best known for her contribution to health promotion and global health. She is adjunct professor at the Graduate Institute of International and Development Studies, Geneva.
Sir Jeremy James Farrar is a British medical researcher who has served as Chief Scientist at the World Health Organization since 2023. He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.
Tedros Adhanom Ghebreyesus is an Ethiopian public health official, researcher, diplomat, and the Director-General of the World Health Organization since 2017. Tedros is the first African to become WHO Director-General, receiving an endorsement for the role by the African Union. He played a role in the response to the Ebola virus epidemic, the COVID-19 pandemic, and the 2022–2023 mpox outbreak.
Recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV), also known as Ebola Zaire vaccine live and sold under the brand name Ervebo, is an Ebola vaccine for adults that prevents Ebola caused by the Zaire ebolavirus. When used in ring vaccination, rVSV-ZEBOV has shown a high level of protection. Around half the people given the vaccine have mild to moderate adverse effects that include headache, fatigue, and muscle pain.
On 20 January 2016, the health minister of Angola reported 23 cases of yellow fever with 7 deaths among Eritrean and Congolese citizens living in Angola in Viana municipality, a suburb of the capital of Luanda. The first cases were reported in Eritrean visitors beginning on 5 December 2015 and confirmed by the Pasteur WHO reference laboratory in Dakar, Senegal in January. The outbreak was classified as an urban cycle of yellow fever transmission, which can spread rapidly. A preliminary finding that the strain of the yellow fever virus was closely related to a strain identified in a 1971 outbreak in Angola was confirmed in August 2016. Moderators from ProMED-mail stressed the importance of initiating a vaccination campaign immediately to prevent further spread. The CDC classified the outbreak as Watch Level 2 on 7 April 2016. The WHO declared it a grade 2 event on its emergency response framework having moderate public health consequences.
On 11 May 2017, the Democratic Republic of the Congo (DRC) was identified by the World Health Organization (WHO) as having one Ebola-related death.
Heidi J. Larson, Lady Piot is an American anthropologist and the founding director of the Vaccine Confidence Project. Larson headed Global Immunisation Communication at UNICEF and she is the author of Stuck: How Vaccine Rumors Start and Why They Don't Go Away. She was recognized as one of the BBC's 100 women of 2021.
Oly Ilunga Kalenga is a Belgian–Congolese medical doctor who was the Democratic Republic of the Congo's Minister of Public Health from 2016 to 2019. He resigned his post on 22 July 2019, then was arrested on 14 September 2019 for allegedly mismanaging a portion of Congo's $4.3 million in Ebola response money, an allegation that he denies.
The Kivu Ebola epidemic was an outbreak of Ebola virus disease (EVD) mainly in eastern Democratic Republic of the Congo (DRC), and in other parts of Central Africa, from 2018 to 2020. Between 1 August 2018 and 25 June 2020 it resulted in 3,470 reported cases. The Kivu outbreak also affected Ituri Province, whose first case was confirmed on 13 August 2018. In November 2018, the outbreak became the biggest Ebola outbreak in the DRC's history, and had become the second-largest Ebola outbreak in recorded history worldwide, behind only the 2013–2016 Western Africa epidemic. In June 2019, the virus reached Uganda, having infected a 5-year-old Congolese boy who entered Uganda with his family, but was contained.
Jean-Jacques Muyembe is a Congolese microbiologist. He is the general director of the Democratic Republic of the Congo Institut National pour la Recherche Biomedicale (INRB). He was part of team at the Yambuku Catholic Mission Hospital that investigated the first Ebola outbreak, and was part of the effort that discovered Ebola as a new disease, although his exact role is still subject to controversy. In 2016, he led the research that designed, along with other researchers at the INRB and the National Institute of Health Vaccine Research Center in the US, one of the most promising treatment for Ebola, mAb114. The treatment was successfully experimented during recent outbreaks in the DRC, on the express decision of the then DRC Minister of Health, Dr Oly Ilunga, despite a prior negative advice from the World Health Organization.
Marie-Paule Kieny is a French virologist, vaccinologist, public health expert and science writer. She is currently director of research at INSERM and chief of the board at DNDi.
Michael Joseph Ryan is an Irish epidemiologist and former trauma surgeon, specialising in infectious disease and public health. He is executive director of the World Health Organization's Health Emergencies Programme, leading the team responsible for the international containment and treatment of COVID-19. Ryan has held leadership positions and has worked on various outbreak response teams in the field to eradicate the spread of diseases including bacillary dysentery, cholera, Crimean–Congo hemorrhagic fever, Ebola, Marburg virus disease, measles, meningitis, relapsing fever, Rift Valley fever, SARS, and Shigellosis.
The Africa Centres for Disease Control and Prevention is a public health agency of the African Union to support the public health initiatives of member states and strengthen the capacity of their health institutions to deal with disease threats. The idea of an African CDC was proposed by the government of Ethiopia in 2013, during a TB/HIV special summit in Abuja, Nigeria. From 2013 to 2016, the modalities and statute of Africa CDC were developed, and the specialized agency was officially launched in January 2017.
John N. Nkengasong is a Cameroonian-American virologist serving as the Global AIDS Coordinator in the Biden administration since 2022 and Senior Bureau Official for Global Health Security and Diplomacy since 2023. He previously worked as the Director of the Africa Centres for Disease Control and Prevention from 2016 to 2022, as well as at the World Health Organization (WHO) and Centers for Disease Control and Prevention. During the COVID-19 pandemic, Nkengasong was appointed the WHO Special Envoy for Africa.
Lothar Heinz Wieler is a German veterinarian and microbiologist who served as president of the Robert Koch Institute (RKI) from 2015 to 2023. In this capacity, he advised the German Federal and State Governments on topics of public health, especially infection hazards, and on the containment of the COVID-19 pandemic.
Flavia Senkubuge is a South African physician, professor of public health medicine, an advocate of global public health and the immediate past President of the Colleges of Medicine of South Africa. At age 39, she was the college's youngest ever president and the first Black woman to hold the position.
Ahmed E. Ogwell Ouma is a Kenyan public health specialist and an expert in health policy, health security, global health diplomacy and non-communicable diseases. He is formerly the acting Director and the Deputy Director-General of the Africa Centres for Disease Control and Prevention. He is currently the Vice President for Global Health Strategy at the United Nations FoundationUN Foundation